Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
5.65
+0.05 (0.89%)
At close: May 6, 2026, 4:00 PM EDT
5.60
-0.05 (-0.88%)
After-hours: May 6, 2026, 6:09 PM EDT
Atea Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
55
Market Cap
452.15M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | 351.37M | 302.73M | 622.49% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vanda Pharmaceuticals | 216.11M |
| Fulcrum Therapeutics | 80.00M |
| ADC Therapeutics | 79.18M |
| Assembly Biosciences | 72.30M |
| Prelude Therapeutics | 12.14M |
| PureTech Health | 4.66M |
| Neurogene | 925.00K |
AVIR News
- 1 day ago - Atea Pharmaceuticals to Host First Quarter 2026 Financial Results and Business Update Conference Call on May 12, 2026 - GlobeNewsWire
- 7 weeks ago - Top 2 Health Care Stocks That May Fall Off A Cliff This Month - Benzinga
- 2 months ago - Atea Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2025 Financial Results and Business Update Conference Call on March 5, 2026 - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals Presents Preclinical Results Supporting First-in-Class Potential of AT-587 for Treatment of Hepatitis E Virus at CROI 2026 - GlobeNewsWire
- 3 months ago - Atea Pharmaceuticals Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 4 months ago - Atea Pharmaceuticals to Highlight 2026 Strategic Priorities at the 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire